Exact Mass: 430.2567
Exact Mass Matches: 430.2567
Found 211 metabolites which its exact mass value is equals to given mass value 430.2567
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Trandolapril
C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09A - Ace inhibitors, plain > C09AA - Ace inhibitors, plain D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents
Trandolapril
Trandolapril is a non-sulhydryl prodrug that belongs to the angiotensin-converting enzyme (ACE) inhibitor class of medications. It is metabolized to its biologically active diacid form, trandolaprilat, in the liver. Trandolaprilat inhibits ACE, the enzyme responsible for the conversion of angiotensin I (ATI) to angiotensin II (ATII). ATII regulates blood pressure and is a key component of the renin-angiotensin-aldosterone system (RAAS). Trandolapril may be used to treat mild to moderate hypertension, to improve survival following myocardial infarction in clinically stable patients with left ventricular dysfunction, as an adjunct treatment for congestive heart failure, and to slow the rate of progression of renal disease in hypertensive individuals with diabetes mellitus and microalbuminuria or overt nephropathy. C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09A - Ace inhibitors, plain > C09AA - Ace inhibitors, plain D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents
Indolapril
Val Ala Asn Lys
8-[2-(3,4-dihydroxy-2,5-dimethoxyoxolan-3-yl)ethyl]-4a,7,8-trimethylspiro[2,3,5,6,7,8a-hexahydro-1H-naphthalene-4,2-oxirane]-2,3-diol
C22H38O8_Spiro[naphthalene-1(2H),2-oxirane]-2,3-diol, octahydro-5,6,8a-trimethyl-5-[2-(tetrahydro-3,4-dihydroxy-2,5-dimethoxy-3-furanyl)ethyl]
8-[2-(3,4-dihydroxy-2,5-dimethoxyoxolan-3-yl)ethyl]-4a,7,8-trimethylspiro[2,3,5,6,7,8a-hexahydro-1H-naphthalene-4,2-oxirane]-2,3-diol
8-[2-(3,4-dihydroxy-2,5-dimethoxyoxolan-3-yl)ethyl]-4a,7,8-trimethylspiro[2,3,5,6,7,8a-hexahydro-1H-naphthalene-4,2-oxirane]-2,3-diol_37.6\\%
8-[2-(3,4-dihydroxy-2,5-dimethoxyoxolan-3-yl)ethyl]-4a,7,8-trimethylspiro[2,3,5,6,7,8a-hexahydro-1H-naphthalene-4,2-oxirane]-2,3-diol_major
8-[2-(3,4-dihydroxy-2,5-dimethoxyoxolan-3-yl)ethyl]-4a,7,8-trimethylspiro[2,3,5,6,7,8a-hexahydro-1H-naphthalene-4,2-oxirane]-2,3-diol_minor
8-[2-(3,4-dihydroxy-2,5-dimethoxyoxolan-3-yl)ethyl]-4a,7,8-trimethylspiro[2,3,5,6,7,8a-hexahydro-1H-naphthalene-4,2-oxirane]-2,3-diol_44.8\\%
Ala Gly Lys Arg
Ala Gly Arg Lys
Ala Lys Gly Arg
Ala Lys Asn Val
Ala Lys Arg Gly
Ala Lys Val Asn
Ala Asn Lys Val
Ala Asn Val Lys
Ala Arg Gly Lys
Ala Arg Lys Gly
Ala Val Lys Asn
Ala Val Asn Lys
Gly Ala Lys Arg
Gly Ala Arg Lys
Gly Ile Lys Asn
Gly Ile Asn Lys
Gly Lys Ala Arg
Gly Lys Ile Asn
Gly Lys Leu Asn
Gly Lys Asn Ile
Gly Lys Asn Leu
Gly Lys Gln Val
Gly Lys Arg Ala
Gly Lys Val Gln
Gly Leu Lys Asn
Gly Leu Asn Lys
Gly Asn Ile Lys
Gly Asn Lys Ile
Gly Asn Lys Leu
Gly Asn Leu Lys
Gly Gln Lys Val
Gly Gln Val Lys
Gly Arg Ala Lys
Gly Arg Lys Ala
Gly Val Lys Gln
Gly Val Gln Lys
Ile Gly Lys Asn
Ile Gly Asn Lys
Ile Lys Gly Asn
Ile Lys Asn Gly
Ile Asn Gly Lys
Ile Asn Lys Gly
Lys Ala Gly Arg
Lys Ala Asn Val
Lys Ala Arg Gly
Lys Ala Val Asn
Lys Gly Ala Arg
Lys Gly Ile Asn
Lys Gly Leu Asn
Lys Gly Asn Ile
Lys Gly Asn Leu
Lys Gly Gln Val
Lys Gly Arg Ala
Lys Gly Val Gln
Lys Ile Gly Asn
Lys Ile Asn Gly
Lys Leu Gly Asn
Lys Leu Asn Gly
Lys Asn Ala Val
Lys Asn Gly Ile
Lys Asn Gly Leu
Lys Asn Ile Gly
Lys Asn Leu Gly
Lys Asn Val Ala
Lys Gln Gly Val
Lys Gln Val Gly
Lys Arg Ala Gly
Lys Arg Gly Ala
Lys Val Ala Asn
Lys Val Gly Gln
Lys Val Asn Ala
Lys Val Gln Gly
Leu Gly Lys Asn
Leu Gly Asn Lys
Leu Lys Gly Asn
Leu Lys Asn Gly
Leu Asn Gly Lys
Leu Asn Lys Gly
Asn Ala Lys Val
Asn Ala Val Lys
Asn Gly Ile Lys
Asn Gly Lys Ile
Asn Gly Lys Leu
Asn Gly Leu Lys
Asn Ile Gly Lys
Asn Ile Lys Gly
Asn Lys Ala Val
Asn Lys Gly Ile
Asn Lys Gly Leu
Asn Lys Ile Gly
Asn Lys Leu Gly
Asn Lys Val Ala
Asn Leu Gly Lys
Asn Leu Lys Gly
Asn Val Ala Lys
Asn Val Lys Ala
Gln Gly Lys Val
Gln Gly Val Lys
Gln Lys Gly Val
Gln Lys Val Gly
Gln Val Gly Lys
Gln Val Lys Gly
Arg Ala Gly Lys
Arg Ala Lys Gly
Arg Gly Ala Lys
Arg Gly Lys Ala
Arg Lys Ala Gly
Arg Lys Gly Ala
Val Ala Lys Asn
Val Gly Lys Gln
Val Gly Gln Lys
Val Lys Ala Asn
Val Lys Gly Gln
Val Lys Asn Ala
Val Lys Gln Gly
Val Asn Ala Lys
Val Asn Lys Ala
Val Gln Gly Lys
Val Gln Lys Gly
AL 6598
5-[2-(3,4-Dihydroxy-2,5-dimethoxytetrahydro-3-furanyl)ethyl]-5,6,8a-trimethyloctahydro-2H-spiro[naphthalene-1,2-oxirane]-2,3-diol
EHop-016
EHop-016 is a potent and selective Rac GTPase Rac1 and Rac3 inhibitor. EHop-016 inhibits Rac1 activity with an IC50 of 1.1 μM in MDA-MB-435 cells. EHop-016 inhibits Vav2 interaction with Rac, Rac-activated PAK1, lamellipodia formation, and cell migration[1][2].
4,4,5,5-tetramethyl-2-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)anthracen-2-yl]-1,3,2-dioxaborolane
1-[2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid
Diphenylacetylene-4,4-diboronic acid bis(pinacol) ester
(2s,3s)-3-Amino-4-[(3s)-3-Fluoropyrrolidin-1-Yl]-N,N-Dimethyl-4-Oxo-2-(Trans-4-[1,2,4]triazolo[1,5-A]pyridin-5-Ylcyclohexyl)butanamide
5-[(E,5S,6S)-5,6-dihydroxy-6-[(2R,3R,5S)-5-[(2R,3S)-3-hydroxy-2-methylbutyl]-3-methyloxolan-2-yl]-3-methylhex-2-enoyl]oxypentanoic acid
(2S)-1-[(2R)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]-1-oxopropyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid
Gln-Lys-Arg
A tripeptide composed of L-glutamine, L-lysine, and L-arginine units joined in sequence by peptide linkages.